Latest filing published 14 Dec 2021 for Castle Biosciences INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Bernhard E. Spiess, listed as senior executive, appears in our data through filings on Castle Biosciences Inc shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 8 June 2021 to 10 December 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 14 December 2021, reports an option exercise in Castle Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations